Events & webinars

HTA (Health Technology Assessment) has long been used to evaluate certain medical devices and diagnostics. Now, a new EU HTA regulation is on the horizon, and it’s poised to bring major changes for the products it…

With the increasing evidence requirements from decision makers, it is essential to evaluate the different opportunities that exist to get reimbursement during the evidence development and government-sponsored clinical…

This webinar is hosted by Athagoras medtech HTA (Health Technology Assessment) has long been used to evaluate certain medical devices and diagnostics. Now, a new EU HTA regulation is on the horizon, and it’s poised to bring…

Germany is a pioneer in establishing a national reimbursement system for digital solutions focused on patients through the DiGA and DIPA process. In this webinar, the following topics will be covered: European overview…

There are many changes happening in France regarding Digital Health. For more information about each topic, click on the topic to see the corresponding blog post: PECA: The new pathway to conditional reimbursement…

In this Webinar, we will explore how the French system for "Coverage with Evidence Development" programs and Innovation Pathways, and how they provide early access to innovative medical devices even when pivotal data is…

There are many changes happening in France regarding Digital Health. For more information about each topic, click on the topic to see the corresponding blog post: PECA: The new pathway to conditional reimbursement…

In this webinar we have the honour of having Dr Morten Schmidt provide an overview of the Danish RWD landscape and the feasibility to utilize this data for outcomes research. He has several publications describing the…

The Nordics are known to provide exceptional opportunities for Real-World-Evidence studies due to the rich data. The countries however have rather different availability of data. In this webinar we will have an…

Don't miss this exciting event about Market Access for Digital Health Solutions arranged by COCIR. Moderator: Dr. Charles Alessi, Editohealth 14:00 – 14:05 Welcome and Introduction, by Annabel Seebohm, COCIR Secretary…

Many medical device companies are aware about the German innovation funding (NUB) for hospital-based procedures. Historically it has proven to be an attractive pathway to establish early reimbursement. A few years ago,…

Many medical device companies are aware about the German innovation funding (NUB) for hospital-based procedures. Historically it has proven to be an attractive pathway to establish early reimbursement. A few years ago,…

In this webinar we will have an opportunity to learn about the status of Market Access for Digital Health in Switzerland. Similar to other countries, there are theoretical ways to establish reimbursement through…

Finnish Digital Health Finland has pioneered the use of HTA for Digital Health and developed a dedicated process named Digi-HTA for such solutions. The Digi-HTA process supports assessments activities for all kind of…

With the temporary ‘ETAP’ solution, France has provided a pathway to establish national reimbursement for digital solutions in specific indications. In addition, it has been possible to apply for ‘brand-specific’…

Mattias Kyhlstedt will deliver a talk at the Nordic E-health conference, Vitalis .…

The ability to use AI and different digital solutions to help guiding the patient journey appears very attractive. A study where patients were triaged by a nurse or a doctor demonstrated a significant increase in number…

mHealthBelgium: a joint initiative for digital health by industry and government You hear it so often: “digital is the future”, and this is also applicable to the health care domain. Apps are used on a daily basis, and…

As part of our COVID-19 Horizon Collaboration Can a ‘simple app’ with data-privacy controls become a significant measure to manage the pandemic? According to the Pepp-PT organization more than 40 countries are…

In this webinar we will provide an update based on the draft legisliation that has been published. Please let us know if you have any specific questions you would like us to address. With the new legislation for…

NICE Evidence Standards Framework for digital health and care technologies Digital health technologies offer the potential for user and system benefits, but many have low levels of evidence to support their…

Our CEO, Mattias Kyhlstedt will be a speaker at The 4th Nordic RWE Conference 2020.

German Digital Reimbursement Act (DVG) - The most important opportunity for digital solutions (globally)? With the new legislation for national reimbursement of digital solutions, Germany has become the single largest…

The new German Digital Reimbursement Act (DVG) – The most important opportunity for digital solutions (globally)? With the new legislation for national reimbursement of digital solutions, Germany has become the single…

Overview: Discussion around the established and evolving NHS datasets being utilised to generate Real World Evidence to support outcomes research. The webinar will also focus on a selection of disease-specific datasets…

Following Part 1 of the webinar, we will present some of tackled methodological issues through practical examples of cost-effectiveness modelling done and/or published by Mihajlović Health Analytics (MiHA). This will…

In this webinar, Michel Verhasselt will share an overview of how the French healthcare system works in regards to market access. The seminar will also cover the different pathways that exist for medical devices,…

Clinical Practice Research Datalink (CPRD) is the preeminent EHR database in the UK, providing de-identified patient data for over 30 years. This webinar aims to give an overview of the CPRD database and research…

This webinar gives an introduction to how the German reimbursement system for in-patient hospital procedures operates. It will provide a brief description of the core-elements of the annual updating cycle and the…

Mathematical modelling of oncological treatments is a dynamic field in which methods are constantly adjusted to correspond to the features of novel therapies. The biggest uncertainty in health economic modelling of such…

In this talk, Vincent Keunen will share the challenges he and his family e ncountered while going through a challenging health crisis: his own cancer, and the cancer of his 10 years old son. He will explain what he…

This seminar is originally designed to help Synergus RWE in how we can better operate as a multi-cultural organisation of employees, as well as to better work with clients from around the world. The seminar will give an…

This webinar will describe how the National Institute for Health Research (NIHR) works in partnership with medical device and diagnostics companies to help them successfully translate ideas into innovative medical…

There can be huge benefits to developing and implementing digital real-world evidence (RWE) studies with patients, advocates and clinicians. But how do you get them on board, and manage their different needs and…

The use of apps to collect patient reported data about quality of life, burden of disease and other variables are exploding. The Nordic countries gives a unique opportunity to combine the use of apps with rich real…

France has a well-developed system to provide solutions for Coverage with Evidence (CED)/Managed introduction. The first solution which has been set up in 2010 with the Article 165.1.1 is the “Forfait Innovation”, which…

In this webinar we will give an introduction to the innovation funding for interventions in the German Hospital care and the link the government sponsored clinical trial. Historically Germany has been a market with easy…

This is the first webinar in a series that we will provide about the methodological framework we use to develop RWE strategies. The focus is on RWE studies with the objective to demonstrate the real world effectiveness…

E-health is a hot topic anticipated to transform healthcare. The mechanisms to fund and pay for e-health solutions are in many countries not as developed as the traditional pathways for drugs, medical devices and…

Webinar: In this webinar we will receive an introduction to the “Model for ASsessment of Telemedicine applications (MAST), developed based on the EUnetHTA model to address the important questions of how to assess…

Webinar E-health is a hot topic anticipated to transform healthcare. The mechanisms to fund and pay for e-health solutions are in many countries not as developed as the traditional pathways for drugs, medical devices…

Seminar / webinar: 101 introduction to reimbursement / funding for e-health and diagnostic companies This webinar gives a basic understanding of the elements relating reimbursement/funding for new innovations in…

This webinar summarises and charts the increasing reliance of clinical outcomes databases and disease registries in supporting HTA decision-making. It will cover the types of data used, why it is used, it’s application…

There is a large unmet need across many diseases requiring big data which single-country or even international registries lack the sample size and power to address. However, combining data from multiple registry sources…

Networks analysis has evolved beyond its earlier applications in social research to become a powerful tool for exploring patterns in complex, highly correlate data. This webinar provides a broad introduction to networks…

Using the MSBase registry, this seminar will describe an example of a clinician-initiated project that translated a series of clinical observations into practical, validated nomogram-based tools for the early prediction…

In this webinar, we will introduce and discuss the critical aspects characterizing the highly regionalized Italian healthcare system, with focus on new Essential Levels of Care and on the mixed financing mechanisms…

Using the large clinician owned and operated MSBase international registry of multiple sclerosis outcomes, this seminar will provide worked examples of how to apply and evaluate propensity score matching as a means of…

This seminar will provide out overview of the challenges and limitations, but also the opportunities associated with the analysis of observational data and registry cohorts, particularly with regards to the study of…

Our presentation will be about: Choosing RWD from the right league changes everything!? What are the different leagues of Real World Data and how does this change the opportunities for related research? Registry Based…

The focus on many medical device companies is on establishing reimbursement, which is mechanism of payment for technology. However, once mechanism is place the very critical element of funding by payers shall be…

The ability to potentially use real world data (RWD) for medical devices is a hot topic in the medical device world. In this half day seminar, we will unlock the possibilities and the limitations in the use of RWE for…

Year of 2016 brought a lot of changes to reimbursement landscape in Europe. Synergus, leading Med Tech consulting company in Europe, is organizing a free Webinar to share our perspective on the most important changes in…

Real World Data – Unlocking the potential for medical device companies The ability to potentially use real world data (RWD) for medical devices is a hot topic in the medical device world. In this half day seminar, we…

In this webinar we will provide an introduction to the NUB funding and overview of how the new benefit assessment will provide impact on the innovation funding process. The new benefit assessment by G-BA and IQWiG will…

Understanding the changes in European Market Access for Medical devices – Reviewing the history of TAVI and comparing what it would look like today? There has been quite a significant change in the European Market…

In this webinar we will provide an introduction to the NUB funding and overview of how the new benefit assessment will provide impact on the innovation funding process. The new benefit assessment by G-BA and IQWiG will…